Recently, in South Korea, colleges have been working hard and researching ways to cure cancer. The cure for cancer is still far; however, medicine has once again advanced with the help of AI.
In the past few days, a professor at KAIST who goes by the name of Kwang-Hyun Cho has made some shocking discoveries with the help of technology. He has been working on reversing the damage caused by cancer cells to try to convert them back to normal cells. The secret was hidden in the genetic network where a molecular switch takes place.
Background on the technology
Cells that are heavily based on the integration of life sciences, physical sciences, engineering, and digital technologies are being referred to as “convergence of innovative therapeutics” and are the biotics being used within treatments that help the artificial intelligence progress further and treat patients. The technology is heavily based on a fast-evolving ecosystem to further improve the medical care patients need. SNUH is currently working ahead to make more ecosystems for clinical researchers to base more research on artificial intelligence.
Cells functionality towards AI
New treatments such as CAR-T therapy play a major role in treating cancer and working alongside AI. Essentially, what this therapy session does is it uses our immune system cells and programs them forward to finding the cancer cells and getting rid of them. The artificial intelligence is said to learn and adapt when finding the cancer cells and make sure to specifically only target them. SNUH is training these cells and producing a manufacturing practice by the name of the GMP system to make sure the new cells are safe and don’t harm the human body. The current focus they aim towards these research is treating those that are more commonly found within Asia, such as T-cell lymphoma and leukemia. As more information comes out, the treatment launch will make sure the patients will only have to do this as a one-time antibiotic.
